⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8462137 | 1.00 | — | — | |
| SCHEMBL262690 | 1.00 | — | — | |
| SCHEMBL246253 | 0.94 | — | — | |
| SCHEMBL346646 | 0.94 | — | — | |
| SCHEMBL1361797 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL29023710 | 0.89 | — | — | |
| Magnesium SCHEMBL31286130 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL27697808 | 0.89 | — | — | |
| Fluoride SCHEMBL27961293 | 0.89 | — | — | |
| SCHEMBL7149269 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110577526-B | Salt of bromodomain structural protein inhibitor and preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-112673009-B | Substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-112771046-B | Other substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-112771046-A | Other substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2021-05-07 | — | — | CN | disclosed |
| CN-112673009-A | Substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2021-04-16 | — | — | CN | disclosed |
| US-20110152246-A1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2011-06-23 | — | — | US | disclosed |